zocdoc
acPhoneNum

Breast Cancer

SWOG S1416
NCI Sponsored
Phase II Randomized Placebo-controlled Trial of Cisplatin with or without ABT-888 (Veliparib) inMetastatic Triple Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer.
View on ClinicalTrials.gov
NRG-BR003
NCI
Sponsored
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
View on ClinicalTrials.gov
Alliance
A011401
NCI Sponsored

Breast Cancer WEight Loss Study (BWEL Study)
View on ClinicalTrials.gov

Fox Chase
16-8003
Industry
Sponsored

Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient via a Provider Didactic Intervention
Not listed on Clinical Trials.gov

DCP-001
NCI Sponsored
Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
Companion study to those marked with *
Not listed on Clinical Trials.gov
EA1131*
NCI Sponsored
A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy vs Capecitabine in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy
View on Clinical Trials.gov
S1207*
NCI Sponsored
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer
View on Clinical Trials.gov
NSABP-B-55*
NCI Sponsored
A Randomised, Double-Blind, Placebo-Controlled Multi-Centre Phase III Study to Assess the Efficacy and Safety of Olaparib Versus Placebo as Adjuvant Treatment in Patients with Germline BRCA1/2 Mutations and High Risk HER2 Negative Primary Breast Cancer Who Have Completed Definitive Local Treatment and Neoadjuvant or Adjuvant Chemotherapy
View on Clinical Trials.gov
E2112*
NCI Sponsored
A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Patients with Hormone Receptor-Positive Advanced Breast Cancer
View on Clinical Trials.gov

Prostate Cancer

CK – 001
Industry
Sponsored
Virtual HDR CyberKnife Radiosurgery for Locally Recurrent Prostatic Carcinoma: a Phase II Study
View on ClinicalTrials.gov
NRG-GU002
NCI Sponsored
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation following Radical Prostatectomy with or without Adjuvant Docetaxel
View on Clinical Trials.gov

 All Disease Sites

RSSearch Patient Registry
Industry Sponsored
A research registry of the de-identified treatment and follow-up data of patients receiving stereotactic radiosurgery (SRS)/stereotactic body radiation therapy (SBRT), including CyberKnife (CK)
View on Clinical Trials.gov
EAY131 “MATCH”
NCI Sponsored
Molecular Analysis for Therapy Choice
(genetic testing in advanced cancers)
View on Clinical Trials.gov
EAQ152
NCI Sponsored
A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Patients with Hormone Receptor-Positive Advanced Breast Cancer     Companion trial to EAY131 (MATCH)
View on Clinical Trials.gov
For information about cancer clinical trials at AtlantiCare, please call the Oncology Clinical Research Coordinator, Kathryn A. Thomas, RN, BSN, OCN, CCRP at 609-677-7735.
© Copyright AtlantiCare 2016. All Rights Reserved.